TotalMarketCap

Biocryst Pharmaceuticals

BCRXNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.953 B

$7.59 -7.89%

Close of 6 Nov 2026

As of 6 Nov 2026, Biocryst Pharmaceuticals (BCRX) has a market capitalization of $1.95B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

$263.9M

#883 by earnings

Shares outstanding

257,299,269

Latest filing cover page

P/E ratio

7.4

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #32Recursion PharmaceuticalsRXRX$2.18B
  2. #33Hemab TherapeuticsCOAG$2.13B
  3. #34Biocryst PharmaceuticalsBCRX$1.95B
  4. #35Replimune GroupREPL$1.90B
  5. #36Vir BiotechnologyVIR$1.89B

What if Biocryst Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$109,743.31

Per share 14,459× higher

Bitcoin $1.53T

$5,938.02

Per share 782× higher

Apple $5.02T

$19,493.96

Per share 2,568× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Biocryst Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.